News Release

CinCor Pharma to Present at Upcoming Jefferies London Healthcare Conference

November 9, 2022 at 8:00 AM EST

WALTHAM, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will participate at the Jefferies London Healthcare Conference taking place on November 15-17, 2022 in London, United Kingdom. The presentation information is below:

Jefferies London Healthcare Conference
Presentation: Wednesday, November 16, 2022 at 5 PM GMT
Location: Track 2 – Room, Adelphi 2, Ground Level at the Waldorf Hilton

The CinCor management team will participate in one-on-one investor meetings during the event. Investors interested in meeting with CinCor at the conference should contact their Jefferies representative.

About CinCor
CinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.

Contacts:   Investors:
Mike Kalb   Bob Yedid
CinCor Pharma, Inc.   LifeSci Advisors

Primary Logo

Source: CinCor Pharma, Inc.